Two Sigma Securities’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,000
Closed -$304K – 2849
2022
Q1
$304K Buy
+4,000
New +$350K 0.01% 1396

Other funds holding TXG

Two Sigma Securities's TXG Position: Q3 2026 in Review

Two Sigma Securities opened a new position in 10x Genomics (TXG) in Q3 2026: 5,643 shares worth $510K. The stake represents 0.04% of the portfolio and ranks #608 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in TXG as recently as Q3 2025.

Two Sigma Securities first reported a position in TXG in Q4 2019 and has held it in 7 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Two Sigma Securities held 5,643 shares of 10x Genomics worth $510K as of Q3 2026.
  • 10x Genomics was a new Two Sigma Securities position in Q3 2026.
  • 10x Genomics made up 0.04% of Two Sigma Securities's portfolio in Q3 2026, its #608 holding.
  • Two Sigma Securities first reported a position in 10x Genomics in Q4 2019 and has held it in 7 quarters since.
  • 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.